Clinical Trials Browser

Observational × camrelizumab × 1 year × Clear all

NCT05387512 2026-01-06

A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer

Lung Neoplasms

NCT07266350 2025-12-05

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

Not yet recruiting

Cervical Cancer Metastatic

NCT05713994 2025-03-25

CCGLC-001

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms